866-997-4948(US-Canada Toll Free)

United States Thalidomide Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

Notes:
Sales, means the sales volume of Thalidomide
Revenue, means the sales value of Thalidomide

This report studies sales (consumption) of Thalidomide in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Allergan
Alnylam Pharmaceuticals
Five Prime Therapeutics
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Enzon Pharmaceuticals
CASI Pharmaceuticals
Celgene Corporation

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Thalidomide in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Thalidomide Market Report 2017
1 Thalidomide Overview
1.1 Product Overview and Scope of Thalidomide
1.2 Classification of Thalidomide
1.2.1 Type I
1.2.2 Type II
1.3 Application of Thalidomide
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Thalidomide (2012-2022)
1.4.1 United States Thalidomide Sales and Growth Rate (2012-2022)
1.4.2 United States Thalidomide Revenue and Growth Rate (2012-2022)

2 United States Thalidomide Competition by Manufacturers
2.1 United States Thalidomide Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Thalidomide Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Thalidomide Average Price by Manufactures (2015 and 2016)
2.4 Thalidomide Market Competitive Situation and Trends
2.4.1 Thalidomide Market Concentration Rate
2.4.2 Thalidomide Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Thalidomide Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Thalidomide Sales and Market Share by States (2012-2017)
3.2 United States Thalidomide Revenue and Market Share by States (2012-2017)
3.3 United States Thalidomide Price by States (2012-2017)

4 United States Thalidomide Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Thalidomide Sales and Market Share by Type (2012-2017)
4.2 United States Thalidomide Revenue and Market Share by Type (2012-2017)
4.3 United States Thalidomide Price by Type (2012-2017)
4.4 United States Thalidomide Sales Growth Rate by Type (2012-2017)

5 United States Thalidomide Sales (Volume) by Application (2012-2017)
5.1 United States Thalidomide Sales and Market Share by Application (2012-2017)
5.2 United States Thalidomide Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Thalidomide Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Thalidomide Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Allergan
6.2.2 Thalidomide Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Allergan Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Alnylam Pharmaceuticals
6.3.2 Thalidomide Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Alnylam Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Five Prime Therapeutics
6.4.2 Thalidomide Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Five Prime Therapeutics Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Angstrom Pharmaceuticals
6.5.2 Thalidomide Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Angstrom Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Acceleron Pharma
6.6.2 Thalidomide Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Acceleron Pharma Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biocon
6.7.2 Thalidomide Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biocon Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Enzon Pharmaceuticals
6.8.2 Thalidomide Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Enzon Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 CASI Pharmaceuticals
6.9.2 Thalidomide Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 CASI Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Celgene Corporation
6.10.2 Thalidomide Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Celgene Corporation Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Thalidomide Manufacturing Cost Analysis
7.1 Thalidomide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Thalidomide

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Thalidomide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Thalidomide Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Thalidomide Market Forecast (2017-2022)
11.1 United States Thalidomide Sales, Revenue Forecast (2017-2022)
11.2 United States Thalidomide Sales Forecast by Type (2017-2022)
11.3 United States Thalidomide Sales Forecast by Application (2017-2022)
11.4 Thalidomide Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Thalidomide
Table Classification of Thalidomide
Figure United States Sales Market Share of Thalidomide by Type in 2015
Table Application of Thalidomide
Figure United States Sales Market Share of Thalidomide by Application in 2015
Figure United States Thalidomide Sales and Growth Rate (2012-2022)
Figure United States Thalidomide Revenue and Growth Rate (2012-2022)
Table United States Thalidomide Sales of Key Manufacturers (2015 and 2016)
Table United States Thalidomide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thalidomide Sales Share by Manufacturers
Figure 2016 Thalidomide Sales Share by Manufacturers
Table United States Thalidomide Revenue by Manufacturers (2015 and 2016)
Table United States Thalidomide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Thalidomide Revenue Share by Manufacturers
Table 2016 United States Thalidomide Revenue Share by Manufacturers
Table United States Market Thalidomide Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Thalidomide Average Price of Key Manufacturers in 2015
Figure Thalidomide Market Share of Top 3 Manufacturers
Figure Thalidomide Market Share of Top 5 Manufacturers
Table United States Thalidomide Sales by States (2012-2017)
Table United States Thalidomide Sales Share by States (2012-2017)
Figure United States Thalidomide Sales Market Share by States in 2015
Table United States Thalidomide Revenue and Market Share by States (2012-2017)
Table United States Thalidomide Revenue Share by States (2012-2017)
Figure Revenue Market Share of Thalidomide by States (2012-2017)
Table United States Thalidomide Price by States (2012-2017)
Table United States Thalidomide Sales by Type (2012-2017)
Table United States Thalidomide Sales Share by Type (2012-2017)
Figure United States Thalidomide Sales Market Share by Type in 2015
Table United States Thalidomide Revenue and Market Share by Type (2012-2017)
Table United States Thalidomide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Thalidomide by Type (2012-2017)
Table United States Thalidomide Price by Type (2012-2017)
Figure United States Thalidomide Sales Growth Rate by Type (2012-2017)
Table United States Thalidomide Sales by Application (2012-2017)
Table United States Thalidomide Sales Market Share by Application (2012-2017)
Figure United States Thalidomide Sales Market Share by Application in 2015
Table United States Thalidomide Sales Growth Rate by Application (2012-2017)
Figure United States Thalidomide Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Thalidomide Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Thalidomide Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Thalidomide Sales Market Share (2012-2017)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Five Prime Therapeutics Thalidomide Sales Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Thalidomide Sales Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Thalidomide Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Thalidomide Sales Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Enzon Pharmaceuticals Thalidomide Sales Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Thalidomide Sales Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Corporation Thalidomide Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thalidomide
Figure Manufacturing Process Analysis of Thalidomide
Figure Thalidomide Industrial Chain Analysis
Table Raw Materials Sources of Thalidomide Major Manufacturers in 2015
Table Major Buyers of Thalidomide
Table Distributors/Traders List
Figure United States Thalidomide Production and Growth Rate Forecast (2017-2022)
Figure United States Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Table United States Thalidomide Production Forecast by Type (2017-2022)
Table United States Thalidomide Consumption Forecast by Application (2017-2022)
Table United States Thalidomide Sales Forecast by States (2017-2022)
Table United States Thalidomide Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *